Back to top

zacks-consensus-estimate: Archive

Zacks Equity Research

Why Is T-Mobile (TMUS) Down 0.1% Since Last Earnings Report?

T-Mobile (TMUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TMUSNegative Net Change VZPositive Net Change

Zacks Equity Research

Why Is Tenet (THC) Down 3.2% Since Last Earnings Report?

Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

THCNegative Net Change

Zacks Equity Research

Waste Connections (WCN) Up 6% Since Last Earnings Report: Can It Continue?

Waste Connections (WCN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

WCNPositive Net Change WMPositive Net Change

Zacks Equity Research

Why Is Wabtec (WAB) Down 5.3% Since Last Earnings Report?

Wabtec (WAB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

WABNegative Net Change

Zacks Equity Research

Why Is Vertiv (VRT) Up 12.2% Since Last Earnings Report?

Vertiv (VRT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

VRTPositive Net Change JKHYPositive Net Change

Zacks Equity Research

Why Is Watts Water (WTS) Down 9.8% Since Last Earnings Report?

Watts Water (WTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

WTSNegative Net Change

Zacks Equity Research

Wall Street Analysts Think Intuitive Surgical (ISRG) Could Surge 29.72%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 29.7% in Intuitive Surgical (ISRG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

ISRGNegative Net Change

Zacks Equity Research

Wall Street Analysts Predict a 35.77% Upside in Stantec (STN): Here's What You Should Know

The consensus price target hints at a 35.8% upside potential for Stantec (STN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

STNNegative Net Change

Zacks Equity Research

Wall Street Analysts See a 103.55% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High?

The mean of analysts' price targets for Q32 Bio (QTTB) points to a 103.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

QTTBPositive Net Change

Zacks Equity Research

Wall Street Analysts Predict a 52.01% Upside in Descartes Systems (DSGX): Here's What You Should Know

The mean of analysts' price targets for Descartes Systems (DSGX) points to a 52% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

DSGXPositive Net Change